IBDEI1RT ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28283,1,4,0)
 ;;=4^G31.9
 ;;^UTILITY(U,$J,358.3,28283,2)
 ;;=^5003815
 ;;^UTILITY(U,$J,358.3,28284,0)
 ;;=G23.8^^115^1386^10
 ;;^UTILITY(U,$J,358.3,28284,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28284,1,3,0)
 ;;=3^Degenerative Diseases of Basal Ganglia NEC
 ;;^UTILITY(U,$J,358.3,28284,1,4,0)
 ;;=4^G23.8
 ;;^UTILITY(U,$J,358.3,28284,2)
 ;;=^5003782
 ;;^UTILITY(U,$J,358.3,28285,0)
 ;;=G30.0^^115^1386^2
 ;;^UTILITY(U,$J,358.3,28285,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28285,1,3,0)
 ;;=3^Alzheimer's Disease w/ Early Onset
 ;;^UTILITY(U,$J,358.3,28285,1,4,0)
 ;;=4^G30.0
 ;;^UTILITY(U,$J,358.3,28285,2)
 ;;=^5003805
 ;;^UTILITY(U,$J,358.3,28286,0)
 ;;=G30.1^^115^1386^3
 ;;^UTILITY(U,$J,358.3,28286,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28286,1,3,0)
 ;;=3^Alzheimer's Disease w/ Late Onset
 ;;^UTILITY(U,$J,358.3,28286,1,4,0)
 ;;=4^G30.1
 ;;^UTILITY(U,$J,358.3,28286,2)
 ;;=^5003806
 ;;^UTILITY(U,$J,358.3,28287,0)
 ;;=B20.^^115^1386^21
 ;;^UTILITY(U,$J,358.3,28287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28287,1,3,0)
 ;;=3^HIV Infection
 ;;^UTILITY(U,$J,358.3,28287,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,28287,2)
 ;;=^5000555
 ;;^UTILITY(U,$J,358.3,28288,0)
 ;;=G10.^^115^1386^22
 ;;^UTILITY(U,$J,358.3,28288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28288,1,3,0)
 ;;=3^Huntington's Disease
 ;;^UTILITY(U,$J,358.3,28288,1,4,0)
 ;;=4^G10.
 ;;^UTILITY(U,$J,358.3,28288,2)
 ;;=^5003751
 ;;^UTILITY(U,$J,358.3,28289,0)
 ;;=G30.8^^115^1386^1
 ;;^UTILITY(U,$J,358.3,28289,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28289,1,3,0)
 ;;=3^Alzheimer's Disease NEC
 ;;^UTILITY(U,$J,358.3,28289,1,4,0)
 ;;=4^G30.8
 ;;^UTILITY(U,$J,358.3,28289,2)
 ;;=^5003807
 ;;^UTILITY(U,$J,358.3,28290,0)
 ;;=A81.89^^115^1386^5
 ;;^UTILITY(U,$J,358.3,28290,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28290,1,3,0)
 ;;=3^Atypical Virus Infections of CNS NEC
 ;;^UTILITY(U,$J,358.3,28290,1,4,0)
 ;;=4^A81.89
 ;;^UTILITY(U,$J,358.3,28290,2)
 ;;=^5000413
 ;;^UTILITY(U,$J,358.3,28291,0)
 ;;=G20.^^115^1386^26
 ;;^UTILITY(U,$J,358.3,28291,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28291,1,3,0)
 ;;=3^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,28291,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,28291,2)
 ;;=^5003770
 ;;^UTILITY(U,$J,358.3,28292,0)
 ;;=G23.1^^115^1386^30
 ;;^UTILITY(U,$J,358.3,28292,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28292,1,3,0)
 ;;=3^Progressive Supranuclear Ophthalmoplegia Palsy
 ;;^UTILITY(U,$J,358.3,28292,1,4,0)
 ;;=4^G23.1
 ;;^UTILITY(U,$J,358.3,28292,2)
 ;;=^5003780
 ;;^UTILITY(U,$J,358.3,28293,0)
 ;;=F03.91^^115^1386^16
 ;;^UTILITY(U,$J,358.3,28293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28293,1,3,0)
 ;;=3^Dementia w/ Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,28293,1,4,0)
 ;;=4^F03.91
 ;;^UTILITY(U,$J,358.3,28293,2)
 ;;=^5133350
 ;;^UTILITY(U,$J,358.3,28294,0)
 ;;=F03.90^^115^1386^18
 ;;^UTILITY(U,$J,358.3,28294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28294,1,3,0)
 ;;=3^Dementia w/o Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,28294,1,4,0)
 ;;=4^F03.90
 ;;^UTILITY(U,$J,358.3,28294,2)
 ;;=^5003050
 ;;^UTILITY(U,$J,358.3,28295,0)
 ;;=G31.84^^115^1386^23
 ;;^UTILITY(U,$J,358.3,28295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28295,1,3,0)
 ;;=3^Mild Cognitive Impairment,So Stated
 ;;^UTILITY(U,$J,358.3,28295,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,28295,2)
 ;;=^5003813
